Keiretsu Backs Savara Pharmaceuticals

Angel investment group Keiretsu Forum said Tuesday that its member invested more than $3M in the Series B funding for Austin's Savara Pharmaceuticals. Keiretsu said it contributed $3M in equity, with the additional $5.4M in the round in the form of conversion of bridge funding. Savara's Series B was worth $8M, and was originally announced in June. More information »